Vaxart Inc (VXRT)
$0.68
0.00 (0.00%)
VXRT Stock Quote Delayed 30 Minutes
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Tuesday's here and with it another busy day of trading for investors as we look at the biggest pre-market stock movers of the day.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
102.58M
PE Ratio
-3.97
EPS
-0.17
Volume (Avg. Vol.)
1,076
Day's Range
-
52-Week Range
$0.52 - $1.54
Dividend & Yield
N/A (N/A)
VXRT Stock Predictions, Articles, and Vaxart Inc News
VXRT Stock: The Big Vaccine News Sending Vaxart Soaring Today
VXRT stock is up huge today as the company announces a coming webinar. Investors are turning bullish as they expect to hear promising news.
Expect Vaxart Stock To Rise on a Unique Approach to Vaccinations
Many people want to be vaccinated, but hardly anybody likes injections. Soon VXRT stock could surge as Vaxart offers a less invasive method.
Vaxart Stock Remains a Buy as Unique Covid-19 Vaccine Is Developed
There are plenty of entrants in the race to develop a Covid-19 vaccine, but distinct advantages mark VXRT stock as a worthy biotech holding.
VXRT Stock: What to Know as Covid-19 Play Vaxart Plummets
Following short-squeeze hopes on Tuesday, Vaxart stock was down Wednesday on news of preliminary Phase I vaccine trial results.
VXRT Stock Alert: 2 Things for Vaxart Investors to Know as Shares Pop Today
Vaxart (VXRT) stock is heading higher Tuesday and there are a couple of things investors will want to keep in mind about the biotech company.
VXRT Stock News: Vaxart Shares Surge on Promising COVID-19 Vaccine News
Vaxart (VXRT) is getting a boost to VXRT stock on Thursday after releasing positive news concerning its vaccine for the novel coronavirus.
Vaxart News: Why VXRT Stock Is Under Fire Today
Vaxart (VXRT) news for Monday isn't good as the company faces a federal investigation and lawsuits over its coronavirus claims.
The Small-Cap Tech Stocks Tripping My Moneyball ‘Buy’ Alerts
Louis Navellier zeroes in on eventual stock winners, spots their key momentum levers, and allows smart folks to learn how to get positioned months or even years before the mainstream media finally catches on.
Trump Coronavirus News: Why the Market Is Sliding Today
The market is sliding on today on Trump coronavirus news following confirmation that President Donald Trump tested positive.
VXRT Stock: Vaxart Shoots Higher on Human Trial Approval
Vaxart just announced it will begin enrolling participants in human trials of its coronavirus vaccine. VXRT stock is popping in response.
4 Catalysts Could Drive Inovio Pharmaceuticals Stock to Near-term Highs
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
Vaxart’s Flu Vaccine Looks Promising, But Its Future Is Uncertain
VXRT soared last week on favorable data. The company is developing a vaccine for the flu. And while the vaccine could be a game changer, VXRT stock still poses notable risks.
